Loading...
•
Dec 31, 2025
Balchem Q4 2025 Earnings Report
Balchem reported record fourth quarter sales and earnings growth in Q4 2025, with higher net income, adjusted EBITDA, and strong free cash flow.
Key Takeaways
In Q4 2025, Balchem generated record net sales of $263617000 and net earnings of $39225000, driven by growth across all three reporting segments. Adjusted EBITDA rose to $67893000 and free cash flow reached $51222000, reflecting strong operational performance.
Net sales increased to $263617000 in the fourth quarter.
Net earnings rose to $39225000 with diluted EPS of $1.21.
Adjusted EBITDA improved to $67893000.
Free cash flow totaled $51222000, supported by solid operating cash flow.
Revenue by Segment
Forward Guidance
The company expressed confidence in continued above-market growth heading into 2026 but did not provide specific quantitative guidance.
Positive Outlook
- Record fourth quarter net sales.
- Growth across all three reporting segments.
- Improved adjusted EBITDA performance.
- Strong free cash flow generation.
- Strengthened balance sheet with low leverage ratio.
Challenges Ahead
- Gross margin percentage declined due to higher manufacturing input costs.
- Operating expenses increased year over year.
- Ongoing exposure to higher input costs.
- Share repurchases reduced cash balances.
- No specific quantitative guidance provided for 2026.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...